Where can I learn more about this study?
You can find more information about this study on the websites listed below. If
more information about the study results is available, it can also be found here.
X www.clinicaltrials.gov. Once you are on the website, type “NCT04478513”
into the search box and click “Search”.
X www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D8730C00007” into the search box, and click “Find a Study”.
Full Study Title: A Phase I, Open-label, Non-randomized Study to Assess the
Effect of Fluvoxamine (CYP1A2 Inhibitor) and Smoking (CYP1A2 Inducer) on the
Pharmacokinetics of a Single Oral Dosing of AZD4635 in Healthy Volunteers
AstraZeneca Protocol Number: D8730C00007
National Clinical Trials Number: NCT04478513
AstraZeneca AB sponsored this study and has its headquarters at Södertälje,
Sweden.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization
focused on educating and informing the public about clinical research participation. CISCRP is not
involved in recruiting participants for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.0 2021_09_09
12 | Clinical Study Results